Interpersonal therapy (IPT)

Article written and reviewed by Dr Luca Moretti

Interpersonal psychotherapy, generally referred to by the acronym IPT, is a structured, present focused psychotherapy originally developed for the treatment of major depression. The model arose from the work of Gerald Klerman, Myrna Weissman and colleagues and integrates a clinical view of depression as a treatable disorder with systematic observation of the relationships among the depressive episode, life events, social roles and the quality of significant relationships. IPT does not assume that interpersonal problems are the sole cause of depression and does not reduce the disorder to a simple consequence of relationships; instead, it considers the interpersonal context a therapeutically modifiable level that may contribute to the onset, maintenance or consequences of the episode.

In treating depression, IPT focuses on relational difficulties that are current, circumscribed and clinically relevant. The therapist helps the patient recognize temporal links between changes in mood and changes in relationships, improve communication and social support, process losses, negotiate conflicts or adapt to new roles. This focus distinguishes IPT from cognitive therapy, which intervenes more directly on cognitive schemas and appraisals, and from behavioral activation, which primarily analyzes relationships among behavior, avoidance, reinforcement and context.

IPT is supported by numerous randomized studies, meta analyses and international guidelines and is one of the psychotherapies with established evidence for depression in adults. Adaptations are available for adolescents, older adults, perinatal depression and other clinical contexts. The presence of grief, conflict or a role transition may make the model particularly intuitive for a patient, but by itself it is not a validated criterion guaranteeing a superior response to IPT compared with other effective psychotherapies.

Clinical model and interpersonal formulation

The IPT formulation starts from the observation that depression and interpersonal functioning can influence one another. A depressive episode can reduce energy, initiative, capacity for pleasure, concentration and stress tolerance, making communication and social participation more difficult; at the same time, losses, persistent conflicts, isolation and role changes can amplify stress, loneliness and feelings of ineffectiveness. Treatment therefore seeks to interrupt this cycle without blaming the patient for the illness and without turning every problematic relationship into a causal explanation of depression.

During the first sessions, the therapist reconstructs the history of the episode, its temporal evolution, previous treatments and social functioning. Interpersonal assessment includes significant relationships, mutual expectations, sources of support, tensions, life events and recent role changes. In parallel, a comprehensive clinical assessment of depression must be performed, including severity, functional impairment, suicide risk, possible psychotic or manic symptoms, substance use, comorbidities and medical conditions that may alter the treatment strategy.

The result is not a generic description of personality, but an interpersonal formulation that links the depressive episode to one or more focal areas amenable to intervention. In classical manuals, these areas are grief, interpersonal disputes, role transitions and interpersonal deficits. In contemporary formulations, the last area may be described in less stigmatizing terms as interpersonal difficulties or sensitivities, isolation or an inadequate support network, while retaining the principle of selecting a circumscribed and observable focus.

In grief the focus concerns the death of a significant person and difficulties in processing the loss, distinguishing the normal grief response from a depressive episode when clinically necessary. In interpersonal disputes incompatible expectations and communication patterns that maintain an important conflict are analyzed. In role transitions the central problem is adaptation to a change, for example separation, retirement, illness, parenthood, migration or loss of a social function. In more pervasive interpersonal difficulties, the work aims to understand recurring patterns and broaden opportunities for relationships and support.

IPT retains a pragmatic orientation: the formulation is used to select specific therapeutic goals, not to demonstrate that an interpersonal category is the definitive biological or psychological cause of the disorder. The focus is agreed with the patient and can be reformulated when new information emerges. This collaborative quality is essential because the same relational situation can have very different meanings, constraints and possibilities for change in different people.

Treatment structure and techniques

Acute IPT is generally a time limited therapy. Classical protocols for depression have often used approximately 12 to 16 sessions, but number, frequency and duration are not fixed and can be adapted to the setting, population and protocol used. Treatment is organized into an initial phase, a middle phase and a concluding phase, with different but continuous objectives.

In the initial phase, diagnosis and severity are defined, the interpersonal context is reconstructed, the focus is identified, goals are agreed and an understandable explanation of the model is provided. The therapist validates that depressive symptoms can temporarily impair functioning and encourages an active role in treatment. When suicide risk, psychosis, mania, severe deterioration in self care or other urgent conditions are present, safety becomes the priority and IPT should not replace necessary medical and psychiatric interventions.

The middle phase uses techniques selected according to the focus. Communication analysis reconstructs conversations and relational episodes in sufficient detail to identify implicit messages, expectations, misunderstandings and possible alternatives. Role playing allows different communication styles to be tried in a protected setting. Exploration of affect helps recognize and use emotions as information about the interpersonal context, while problem solving can be used to define concrete options without turning the entire treatment into PST.

In disputes, the therapist helps clarify the stage of the conflict, the expectations of the parties and realistic possibilities for negotiation or change. In role transitions, work focuses on comparing the old and new role, losses associated with the change, required skills and new sources of support. In grief, treatment facilitates processing of the lost relationship and progressive reinvestment in current life. When there is isolation or recurrent interpersonal difficulty, recent examples are analyzed and opportunities for more functional contact are developed.

The ending is an integral part of therapy. The therapist makes the end of treatment explicit, reviews changes achieved, identifies strategies the patient can continue to use and discusses early warning signs of relapse and ways to seek help. Any sadness or concern associated with therapeutic separation is treated as a meaningful interpersonal experience without automatically interpreting it as pathology.

The therapeutic relationship is active and supportive, but IPT is not synonymous with generic supportive therapy. The therapist maintains the focus and links narrated events to agreed goals. At the same time, simplistic prescriptions about relationships are avoided because safety, economic dependence, violence, discrimination, illness and other real constraints may limit what can be changed through communication alone.

Indications, adaptations and patient selection

The most extensively studied indication is major depression. International guidelines include IPT among evidence based psychological interventions, but there is no rule that it must automatically be selected whenever a relational problem is present. Treatment selection should integrate episode severity and duration, treatments that were previously effective or ineffective, comorbidities, preferences, accessibility, therapist expertise and the need for concomitant pharmacotherapy.

IPT has been adapted for adolescence, later life, perinatal and postpartum depression and different delivery formats. Specific randomized studies support its efficacy in postpartum depression. During this phase of life, the model can address role changes, the couple relationship, restructuring of the support network and expectations regarding parenthood, but assessment must still include suicide risk, psychotic symptoms, possible bipolar disorder and the safety of both mother and infant.

In older adults, therapy can be adapted to multiple bereavements, medical illness, retirement, changes in autonomy and reduction of the social network. Cognitive, sensory or motor difficulties may require practical modifications to the setting. In adolescents, work gives greater consideration to family, school, peers and developmental transitions. These adaptations are not simple transfers of the adult version and require specific training.

The treatment may be less suitable when the patient does not wish to work on the relational context or when another intervention addresses the priority problem more directly. Comorbid disorders, trauma, addictions, personality disorders or medical conditions are not universal exclusions, but may require integrated treatment, a different treatment sequence or specific protocols.

IPT can be delivered individually and, in adapted protocols, in groups or through formats other than the traditional weekly meeting. Efficacy in one format should not automatically be transferred to all others: the level of evidence depends on the population, protocol, implementation quality and availability of supervision and clinical monitoring.

Informed preference is particularly important because an interpersonal focus requires willingness to discuss current relationships and try new communication approaches. Some patients may prefer more directly behavioral or cognitive work; others may find IPT more consistent with how they understand the episode. When several evidence based options are appropriate, this fit between treatment rationale and preferences may support adherence without being confused with a biological predictor of response.

Efficacy in depression and comparison with other treatments

Meta analyses of randomized trials show that IPT reduces depressive symptoms compared with control conditions and is one of the major psychotherapies studied for depression. Indirect comparisons among psychotherapies do not demonstrate universal and clinically large superiority of a single model for all patients. Differences observed across studies also depend on severity, setting, comparator, risk of bias, treatment fidelity and sample characteristics.

A meta analysis specifically focused on IPT confirmed efficacy both as a standalone treatment and in combination with pharmacotherapy. A subsequent comprehensive meta analysis found benefits of IPT in depression and also examined its use in other disorders. The 2021 network meta analysis of major psychotherapies for depression places IPT among evidence supported approaches, while emphasizing the need to consider methodological quality and the durability of effects over time.

Direct comparison with antidepressants does not justify concluding that the two treatments are interchangeable in every situation. An individual patient data meta analysis published in 2024 compared IPT and antidepressant pharmacotherapy on symptoms and other outcomes; overall, it does not support a rigid choice based on the idea that one modality is always superior. Clinical decisions must also consider preferences, pharmacological adverse effects, response history, risk, comorbidities and psychotherapy availability.

In more severe or complex presentations, combination of psychotherapy and pharmacotherapy may be appropriate. Here too there is no automatic rule: guideline recommendations distinguish according to severity, previous response, risk and preferences. Psychotherapy should not delay necessary interventions in severe depression with suicide risk, catatonia, psychotic symptoms, mania or severe impairment of nutrition and hydration.

For relapse prevention, historical data exist on maintenance strategies with IPT, including in combination or comparison with pharmacotherapy. These findings support the principle that interpersonal work may continue beyond the acute phase in selected patients, but they do not mean that every patient should indefinitely receive the same session frequency. Continuation and maintenance strategies should be individualized according to recurrence history and residual risk.

Monitoring, safety and limitations of interpretation

The course of IPT should be monitored through clinical assessment and, when useful, standardized measures of depressive symptoms and functioning. Insufficient symptom reduction requires checking diagnosis, adherence, focus quality, comorbidities, persistent stressors and adequacy of treatment intensity. Simply having identified an interpersonal area does not demonstrate that treatment is working.

The therapist should periodically reassess suicide risk and other indicators of deterioration. Increased activation, reduced need for sleep, grandiosity or other signs of possible mania require prompt diagnostic reassessment. In cases of domestic violence or coercion, the goal cannot be reduced to improving communication with the aggressor: safety and access to appropriate resources take priority.

Research on IPT has limitations common to the psychotherapy literature, including the impossibility of complete blinding of participants and therapists, heterogeneity of comparators, differences in therapist experience and possible publication bias. Average study results therefore cannot predict with certainty the response of an individual patient and should not be turned into promises of remission.

IPT nevertheless remains a well characterized, manualized treatment with a broad empirical evidence base for depression. Its clinical value lies in translating the relationship between symptoms and interpersonal life into a focused, observable and shared treatment plan while maintaining a comprehensive psychiatric assessment and a treatment choice consistent with guidelines.

Interpersonal functioning should also be assessed carefully: symptom improvement may precede changes in relationships or vice versa. If the patient remains exposed to unmodifiable conflict, structural isolation or heavy caregiving burdens, the therapist may need to integrate social and healthcare resources. IPT should not turn social determinants or other people's behavior into an exclusively psychological task for the patient.

Fidelity to the focus is important but should not prevent recognition of a diagnostic change. Emerging symptoms of trauma, obsessive compulsive disorder, problematic substance use or other conditions may require a more specific protocol. In that case, modifying the treatment plan is a sign of good practice, not failure of IPT.

Integration into the treatment pathway and prognosis

Within depression care, IPT can be selected as the primary psychotherapy, combined with an antidepressant or included in a treatment sequence. In patients who prefer a psychological approach and whose clinical situation allows it, it can represent a valid initial alternative. In patients already receiving pharmacological treatment, it may be added when symptoms, interpersonal difficulties or relapse risk persist, provided the indication derives from a comprehensive assessment rather than from the relational content of symptoms alone.

Prognosis depends more on the overall depression than on the name of the psychotherapy used: the number and severity of previous episodes, residual symptoms, comorbidities, chronic stress, social support, adherence and continued access to care influence relapse risk. A good response to IPT does not eliminate the need to recognize new symptoms early and maintain a prevention plan appropriate to individual risk.

When treatment is beneficial, expected outcomes include not only symptom reduction but also improved social functioning, greater ability to manage transitions and conflicts, and better use of the support network. These outcomes are clinically relevant, but they should be verified in the individual patient rather than assumed from the theoretical model.

The continuation phase may include less frequent sessions or a booster plan, depending on risk and protocol. In patients with recurrent episodes, it is important to distinguish prevention of relapse of the same episode from prevention of new recurrences over the long term. Decisions about psychotherapeutic and pharmacological maintenance should consider these goals separately and reassess them over time.

A favorable conclusion of IPT does not require every relationship to be resolved. A realistic outcome may be the ability to recognize conflict earlier, communicate needs more clearly, use available support and manage a transition without progressive withdrawal. Prognosis nevertheless remains determined by the interaction among individual vulnerability, depressive course and social context.

Bibliography
1. Cuijpers P et al. Interpersonal psychotherapy for depression: a meta-analysis. American Journal of Psychiatry. 168(6), 2011, 581-592.
2. Cuijpers P et al. Interpersonal Psychotherapy for Mental Health Problems: A Comprehensive Meta-Analysis. American Journal of Psychiatry. 173(7), 2016, 680-687.
3. Cohen ZD et al. Comparative efficacy of interpersonal psychotherapy and antidepressant medication for adult depression: a systematic review and individual participant data meta-analysis. Psychological Medicine. 54(14), 2024, 3785-3794.
4. O’Hara MW et al. Efficacy of interpersonal psychotherapy for postpartum depression. Archives of General Psychiatry. 57(11), 2000, 1039-1045.
5. Frank E et al. Three-year outcomes for maintenance therapies in recurrent depression. Archives of General Psychiatry. 47(12), 1990, 1093-1099.
6. Weissman MM et al. The Guide to Interpersonal Psychotherapy. Updated and Expanded Edition. Oxford University Press, 2018.
7. National Institute for Health and Care Excellence. Depression in adults: treatment and management. NICE guideline NG222. 2022; last reviewed 2026.
8. Lam RW et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults. Canadian Journal of Psychiatry. 69(9), 2024, 641-687.
9. Department of Veterans Affairs, Department of Defense. VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder. Version 4.0. Washington, DC, 2022.
10. American Psychological Association. Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts. Washington, DC: American Psychological Association, 2019.
11. Cuijpers P et al. Psychotherapies for depression: a network meta-analysis covering efficacy, acceptability and long-term outcomes of all main treatment types. World Psychiatry. 20(2), 2021, 283-293.
12. Cuijpers P et al. Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: a comprehensive meta-analysis including 409 trials with 52,702 patients. World Psychiatry. 22(1), 2023, 105-115.
13. Cuijpers P et al. Psychologic Treatment of Depression Compared With Pharmacotherapy and Combined Treatment in Primary Care: A Network Meta-Analysis. Annals of Family Medicine. 19(3), 2021, 262-270.
14. Cuijpers P et al. Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis. World Psychiatry. 13(1), 2014, 56-67.